UR-144
UR-144 is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but with much lower affinity for the psychoactive CB1 receptor. Chemically it is closely related to other 2,2,3,3-tetramethylcyclopropyl synthetic cannabinoids like A-796,260 and A-834,735 but with a different substitution on the 1-position of the indole core, in these compounds its 1-pentyl group is replaced with alkylheterocycles like 1-(2-morpholinoethyl) and 1-(tetrahydropyran-4-ylmethyl).| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-Cr3744 | UR-144-BSA Antigen | UR-144-BSA Antigen, Hapten:Protein=30:1; Used for ELISA, Lateral Flow. | UR-144 | Drugs of Abuse |  |
1 mg | Inquiry | |
| VAng-Cr3745 | UR-144-BSA Antigen | UR-144-BSA Antigen; Used for ELISA, Lateral Flow. | UR-144 | Drugs of Abuse | |
1 mg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
